Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anthem BiosciencesNSE:ANTHEM +0.36%34 Dividend Yield % is 0.27% as of Jul. 13, 2026. GuruFocus rates NSE:ANTHEM with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 153 Biotechnology companies, Anthem Biosciences ranks worse than 92.16% on this metric.
As of today (2026-07-13), the Trailing Annual Dividend Yield of Anthem Biosciences is 0.27%.
The historical rank and industry rank for Anthem Biosciences's Dividend Yield % or its related term are showing as below:
NSE:ANTHEM'
s Dividend Yield % Range Over the Past 10 Years
Min: 0 Med: 0 Max: 0.27
Current: 0.27
During the past 5 years, the highest Dividend Yield of Anthem Biosciences was 0.27%. The lowest was 0.00%. And the median was 0.00%.
NSE:ANTHEM's Dividend Yield % is ranked worse than 92.16% of 153
companies
in the Biotechnology industry
Industry Median: 1.38
vs NSE:ANTHEM: 0.27
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Anthem Biosciences Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Anthem Biosciences's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ANTHEM vs VRTX, REGN, ALNY: Dividend Yield % Comparison
For the Biotechnology subindustry, Anthem Biosciences's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anthem Biosciences Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anthem Biosciences's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Anthem Biosciences's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Anthem Biosciences Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
INR 2.000000
2026-06-25
2026-06-26
2026-08-21
Cash Dividend
annually
INR:INR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Anthem Biosciences's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anthem Biosciences (NSE:ANTHEM) has a Dividend Yield % of 0.27% as of Jul. 13, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Anthem Biosciences and its competitors. According to the industry distribution chart, Anthem Biosciences ranks #141 out of 153 companies in the Biotechnology industry, placing it in the top 92.2%.
Is Anthem Biosciences' Dividend Yield % too high?
Anthem Biosciences' current Dividend Yield % is 0.27%. The Biotechnology industry median Dividend Yield % is 1.38. Anthem Biosciences' value of 0.27% is 80.4% below this industry median. Based on the distribution chart, Anthem Biosciences ranks #141 out of 153 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Anthem Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' Dividend Yield % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anthem Biosciences ranks #141 out of 153 companies for Dividend Yield %. This places Anthem Biosciences in the lower half of its industry. The industry median Dividend Yield % is 1.38. Anthem Biosciences' value of 0.27% is 80.4% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Biotechnology company?
The median Dividend Yield % among Biotechnology companies is 1.38, based on 153 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Anthem Biosciences's current Dividend Yield % of 0.27% is 80.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Anthem Biosciences and its competitors. For the Biotechnology industry, the median Dividend Yield % is 1.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anthem Biosciences's current Dividend Yield % is 0.27%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current Dividend Yield % of 0.27%. The current Dividend Yield % is 0.27% and 80.4% below the Biotechnology industry median of 1.38. Anthem Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current Dividend Yield % is 0.27% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
34GF Score
Get the complete analysis for NSE:ANTHEM
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ANTHEM has been successfully added to your 
